InvestorsHub Logo
Followers 38
Posts 1440
Boards Moderated 0
Alias Born 03/07/2004

Re: Thurly post# 54278

Friday, 07/23/2010 6:41:09 PM

Friday, July 23, 2010 6:41:09 PM

Post# of 346050
Thurly,goodpost. What vaccine crazed fool virologist wrote it? Duke?They are not PPHM friends there. They pick brains,then try to apply it to vaccines that induce the body to produce antibodies. PPHM MAKES the antibody in its own FDA-approved manufacturing facility, Avid. He said they've [finally] learned that targeting a specific viral envelope epitope doesn't get it. Can't "vaccinate" against AIDS. Their strategy didn't work. "It only worked against viruses of an exact type that you used to get the envelope from. So it wouldn’t work against a wide … the majority of HIVs."
Duke learned a lot about -PS cell surface docking sites from PPHM, helping thrust -PS chemistry to the front burner-- all the rage now judged by the mushrooming publications on that genre in the scientific literature. "So," he continues, whoever he is, "our approach [is] different....we are now focusing on regions of the envelope that cannot change, regions that must be conserved and not mutate, not change." [that sounds like -PS sites. "The virologists are looking for cell surface regions that are non-mutable and also functionally required for the virus to begin the infection process. He continues, "We have focused on such regions that are normally protected by complex mechanisms against an attack by antibodies. And we worked on a method that exposes..."[here he sounds confused]... you make a vaccine that will make antibodies that will work when these regions are exposed." [Note, "a vaccine that makes antibodies"] "We have interesting results. We’re trying to move this forward to the very beginning of clinical testing for safety. Interesting results in animals." Bunko. Gibberish. Not Bavi.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News